All the news Showing 10 of 102 articles from: Treatment outcomesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources 7% of patients coinfected with HCV and HIV fail DAA therapy Healio / 14 March 2019 DAA treatment reduces the risk of death and liver cancer in France Keith Alcorn / 12 February 2019 Treatment with direct-acting antivirals (DAAs) reduced the risk of death, liver cancer and death from liver-related causes in French people with hepatitis C, according to results of one of the largest studies ... Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost Michael Carter / 01 February 2019 Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved ... Interferon-Free Hepatitis C Treatments Effective in Elderly Patients Infectious Disease Advisor / 23 January 2019 DAA Treatment and Hepatic Fibrosis Improvement in HCV: What's the Link? Monthly Prescribing Reference / 14 November 2018 Sofosbuvir/ledipasvir cures most young children with hepatitis C Liz Highleyman / 13 November 2018 Almost all young children ages 3 to 6 years with chronic hepatitis C achieved sustained virological response after 12 weeks of treatment using sofosbuvir/ledipasvir oral granules, according to findings presented at the ... Successful hepatitis C treatment lowers risk of cardiovascular events Liz Highleyman / 25 October 2018 Treatment for hepatitis C, especially if it leads to a cure, is associated with a reduced risk of cardiovascular events such as congestive heart failure, heart attacks and strokes, according to research presented ... Anti-virals cure up to 98% of hepatitis C patients since 2014 Irish Times / 09 October 2018 Psychological relief is the most important benefit of a hepatitis C cure for patients Roger Pebody / 13 September 2018 When asked to describe what their hepatitis C cure meant to them, Australians who had recently completed treatment emphasised an improved sense of psychological wellbeing, according to a qualitative study recently published in ... Reinfection risk after hepatitis C treatment higher in recent drug users Keith Alcorn / 07 September 2018 Reinfection with hepatitis C after successful treatment is more common in younger people who inject drugs and recent and former drug users are at greatest risk of reinfection, a cohort study in ... ← Prev12345...11Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive